Skip to main content
Shanghai Xuerong Biotechnology Co.,Ltd. logo

Shanghai Xuerong Biotechnology Co.,Ltd. — Investor Relations & Filings

Ticker · 300511 ISIN · CNE100002706 LEI · 300300GD8D1H8VMRLO14 Shenzhen Stock Exchange Agriculture, forestry and fishing
Open in API
Filings indexed 1,921 across all filing types
Latest filing 2026-06-09 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300511

About Shanghai Xuerong Biotechnology Co.,Ltd.

https://www.xuerong.com

Shanghai Xuerong Biotechnology Co.,Ltd. specializes in the industrial cultivation and distribution of high-quality edible fungi. Utilizing advanced biotechnological processes and automated factory-style production facilities, the company focuses on the large-scale cultivation of various mushroom species, including Enoki, Beech, Crab-flavored, and White Beech mushrooms. The organization integrates research and development, strain cultivation, and modern agricultural techniques to ensure consistent quality and high yields. By implementing standardized environmental control systems and circular economy principles, the company maintains a leading position in the edible fungi sector, supplying fresh products to various markets. Its operations emphasize food safety, sustainable agricultural practices, and the application of modern science to traditional mushroom farming.

Recent filings

Filing Released Lang Actions
上海雪榕生物科技股份有限公司关于持股5%以上股东股份被司法冻结的公告
Regulatory Filings Classification · 72% confidence The document is an announcement of a judicial freeze on shares held by a >5% shareholder. It is a routine regulatory disclosure about share restrictions, not a financial report, vote results, board change, capital transaction, or share issue. It falls under the general “Regulatory Filings” category for miscellaneous compliance-related announcements.
2026-06-09 Chinese
上海雪榕生物科技股份有限公司2025年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document is an official announcement of the results of the company’s 2025 Annual General Meeting, detailing attendance, vote counts and the passing or rejection of each resolution. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement.
2026-05-29 Chinese
国浩律师（上海）事务所关于上海雪榕生物科技股份有限公司2025年年度股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a legal opinion letter (法律意见书) on the convening, attendance, procedures, and detailed voting outcomes of the 2025 Annual General Meeting of Shanghai Xuerong Bio-Tech Co., Ltd. It provides the official vote counts and percentages for each AGM resolution. According to our taxonomy, any filing that announces the official results from shareholder votes at an AGM falls under “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-05-29 Chinese
上海雪榕生物科技股份有限公司关于终身名誉董事长2026年度薪酬方案暨关联交易的公告
Remuneration Information Classification · 92% confidence The document is an announcement regarding the 2026 annual remuneration scheme for the company’s lifetime honorary chairman and constitutes a related-party transaction. It details the compensation structure (monthly salary, annual performance pay), related-party definitions, board approval votes, independent director opinions, and adherence to exchange rules. This aligns with a Remuneration Information filing (detailed compensation for top executives/directors) rather than a change in board composition or a simple regulatory notice.
2026-04-27 Chinese
上海雪榕生物科技股份有限公司第六届董事会第七次会议决议公告
Board/Management Information Classification · 92% confidence The document is a formal announcement of the resolutions passed at the sixth session of the company’s seventh Board of Directors meeting, covering items such as approval of reports, annual report submission, audit firm reappointment, profit distribution proposals, remuneration schemes, and convening of the shareholders’ meeting. It does not itself contain financial results (so not an ER or IR), is not the full annual or quarterly report (just refers to them), nor a regulatory notice of report publication alone. It is neither a transcript, capital update, nor voting results. This is clearly a Board/Management Information announcement (resolutions of the board meeting).
2026-04-27 Chinese
上海雪榕生物科技股份有限公司董事会关于独立董事独立性情况的专项意见
Governance Information Classification · 85% confidence The document is an announcement by the board of Shanghai Xuerong Biotechnology Co., Ltd. providing a special opinion on the independence of its independent directors under relevant listing rules and exchange guidelines. This is not reporting a change in board composition (so not MANG), nor is it an annual or interim financial report. Instead, it details a governance practice concerning board independence. Therefore it best fits the Governance Information category (CGR).
2026-04-27 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.